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The crystal structures of BB2672 and SPO0826 were determined to resolutions
of 1.7 and 2.1 A ˚ by single-wavelength anomalous dispersion and multiple-
wavelength anomalous dispersion, respectively, using the semi-automated high-
throughput pipeline of the Joint Center for Structural Genomics (JCSG) as part
of the NIGMS Protein Structure Initiative (PSI). These proteins are the ﬁrst
structural representatives of the PF06684 (DUF1185) Pfam family. Structural
analysis revealed that both structures adopt a variant of the Bacillus chorismate
mutase fold (BCM). The biological unit of both proteins is a hexamer and
analysis of homologs indicates that the oligomer interface residues are highly
conserved. The conformation of the critical regions for oligomerization appears
to be dependent on pH or salt concentration, suggesting that this protein might
be subject to environmental regulation. Structural similarities to BCM and
genome-context analysis suggest a function in amino-acid synthesis.
1. Introduction
To extend the structural coverage of proteins of unknown function,
we targeted Pfam protein family PF06684 (domain of unknown
function1185;DUF1185)anddeterminedthecrystalstructuresoftwo
representative members. The BB2672 gene of Bordetella bronchi-
septica, which is a causative agent of infectious bronchitis in domestic
mammals, encodes a protein with a molecular weight of 20.9 kDa
(residues 1–192) and a calculated isoelectric point of 7.1. The
SPO0826geneofthemarine -proteobacterium Silicibacterpomeroyi
encodes a protein with a molecular weight of 20.5 kDa (residues
1–193) and a calculated isoelectric point of 6.2.
Here, we report the crystal structures of BB2672 and SPO0826,
which were determined using the semi-automated high-throughput
pipeline of the Joint Center for Structural Genomics (JCSG; http://
www.jcsg.org; Lesley et al., 2002) as part of the NIGMS Protein
Structure Initiative (PSI). Despite lacking any recognizable sequence
similarity to other protein families, both proteins show signiﬁcant
structural similarity to proteins with a Bacillus chorismate mutase-
like (BCM-like) fold characterized by a  - - - - -  core that
includes a mixed  -sheet (order 1423) with the  4 strand antiparallel
to the rest. In bacteria, fungi and higher plants, chorismate mutase
(EC 5.4.99.5) catalyzes the isomerization of chorismate to prephenate
in the ﬁrst committed step in the biosynthesis of the aromatic amino
acids phenylalanine and tyrosine. While bifunctional chorismate
mutases are all-  proteins that form dimers and exhibit feedback
inhibition and allostery (Schmidheini et al., 1990), the mono-
functional chorismate mutase adopts a BCM-like fold, is trimeric and
follows Michaelis–Menten kinetics. Analysis of the BB2672 crystallo-
graphic hexamer reveals a trimer of dimers, with two distinct types of
dimerization interface created by an extra N-terminal strand and a
 -hairpin insertion between strands  3 and  4 in the core BCM-like
fold. The more extensive interface, which is located at the C-terminus,
contains a network of histidine and salt-bridged residues that may
indicate environmental regulation of hexamer assembly. The smaller
interface at the N-terminus could present a potential ligand-binding
site for the DUF1185 family, the genetic context of which supports a
role in amino-acid metabolism.2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE) cloning method (Klock et al., 2008). The genes
encoding B. bronchiseptica RB50 BB2672 (GenBank NP_889209.1,
gi:33601649, Swiss-Prot Q7WJ28) and S. pomeroyi DSS-3 SPO0826
(GenBank YP_166079.1, gi:56695728, Swiss-Prot Q5LV76) were
ampliﬁed by polymerase chain reaction (PCR) from genomic DNA
using PfuTurbo DNA polymerase (Stratagene) and I-PIPE (Insert)
primers (BB2672 forward primer, 50-ctgtacttccagggcATGTCTT-
TGTACGAAATCCGCAAGCGC-30; BB2672 reverse primer,
50-aattaagtcgcgttaGCGCTGGCCGTCGTGCACCGAGACGGC-30;
SPO0826 forward primer, 50-ctgtacttccagggcATGACCAAGATCC-
GCAAGATCGCTG-30; SPO0826 reverse primer, 50-aattaagtcgcgtt-
aTCTCAGGCCGTCCTTGCCTTCGGCCGCG-30; target sequences
are shown in upper case) that included sequences for the predicted 50
and 30 ends. The expression vector pSpeedET, which encodes
an amino-terminal tobacco etch virus (TEV) protease-cleavable
expression and puriﬁcation tag (MGSDKIHHHHHHENLYFQ/G),
was PCR-ampliﬁed with V-PIPE (Vector) primers (forward primer,
50-taacgcgacttaattaactcgtttaaacggtctccagc-30; reverse primer, 50-gcc-
ctggaagtacaggttttcgtgatgatgatgatgatg-30). V-PIPE and I-PIPE PCR
products were mixed to anneal the ampliﬁed DNA fragments toge-
ther. Escherichia coli GeneHogs (Invitrogen) competent cells were
transformed with the V-PIPE/I-PIPE mixture and dispensed onto
selective LB–agar plates. The cloning junctions were conﬁrmed
by DNA sequencing. Protein expression was performed in seleno-
methionine-containing medium at 310 K with suppression of normal
methionine synthesis. At the end of fermentation, lysozyme was
added to the cultures to a ﬁnal concentration of 250 mgm l
 1 and the
cells were harvested. After one freeze–thaw cycle, the cells were
homogenized in lysis buffer [50 mM HEPES pH 8.0, 50 mM NaCl,
10 mMimidazole, 1 mMtris(2-carboxyethyl)phosphine hydrochloride
(TCEP)] and passed through a Microﬂuidizer (Microﬂuidics). The
lysates were clariﬁed by centrifugation at 32 500g for 30 min and
loaded onto nickel-chelating resin (GE Healthcare) pre-equilibrated
with lysis buffer; the resin was washed with wash buffer [50 mM
HEPES pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol,
1m M TCEP] and the proteins were eluted with elution buffer
[20 mM HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP]. The eluates were buffer-exchanged with crystallization buffer
(20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM
TCEP) using PD-10 columns (GE Healthcare). The BB2672 PD-10
and SPO0826 eluates were treated with 1 mg TEV protease per
15 mg of eluted protein. The digested protein was passed over nickel-
chelating resin pre-equilibrated with crystallization buffer and the
resin was washed with the same buffer. The ﬂowthrough and
wash fractions were combined and concentrated to 20 mg ml
 1 by
centrifugal ultraﬁltration (Millipore) for crystallization assays. For
SPO0826, TEV cleavage of the expression and puriﬁcation tag was
unsuccessful and the PD-10 eluate was therefore further puriﬁed on a
HiLoad 16/60 Superdex 200 column (GE Healthcare) using crystal-
lization buffer as the mobile phase. The peak fractions were pooled
and concentrated to 15 mg ml
 1 by centrifugal ultraﬁltration for
crystallization assays. The two proteins were crystallized by mixing
100 nl protein solution with 100 nl crystallization solution with a 50 ml
reservoir volume using the nanodrop vapor-diffusion method
(Santarsiero et al., 2002) with standard JCSG crystallization protocols
(Lesley et al., 2002). Screening for diffraction was carried out using
the Stanford Automated Mounting system (SAM; Cohen et al., 2002)
at the Stanford Synchrotron Radiation Lightsource (SSRL, Menlo
Park, California, USA). For BB2672, the crystallization reagent
consisted of 20%(w/v) polyethylene glycol 8000 and 0.1 M CHES
pH 9.5. Ethylene glycol (1,2-ethanediol) was added to a ﬁnal con-
centration of 10%(v/v) as a cryoprotectant. A plate-shaped crystal of
approximate dimensions 0.1   0.04   0.02 mm was harvested after
26 d at 277 K for data collection. The BB2672 diffraction data were
indexed in the orthorhombic space group C2221 (Table 1). For
SPO0826, the crystallization reagent consisted of 0.1 M NaH2PO4,
0.1 M KH2PO4,2 M NaCl and 0.1 M MES pH 6.5. Glycerol was
added to a ﬁnal concentration of 15%(v/v) as a cryoprotectant. A
crystal of approximate dimensions 0.3   0.2   0.2 mm was harvested
after 15 d at 277 K for data collection. The SPO0826 diffraction data
were indexed in the tetragonal space group P43212 (Table 2). The
oligomeric states of BB2672 and SPO0826 were determined using a
1   30 cm Superdex 200 size-exclusion column (GE Healthcare)
coupled with miniDAWN static light-scattering (SEC/SLS) and
Optilab differential refractive-index detectors (Wyatt Technology).
The mobile phase consisted of 20 mM Tris pH 8.0, 150 mM NaCl and
0.02%(w/v) sodium azide. The molecular weight was calculated using
ASTRA v.5.1.5 software (Wyatt Technology).
2.2. Data collection, structure solution and refinement
For BB2672, single-wavelength anomalous diffraction (SAD) data
were collected on beamline BL11-1 at SSRL at a wavelength corre-
sponding to the peak of a selenium SAD experiment. The data were
collected at 100 Kon a MAR Mosaic 325 mm CCD detector using the
structural communications
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Table 1
Summary of crystal parameters, data-collection and reﬁnement statistics for
BB2672 (PDB code 3byq).
Values in parentheses are for the highest resolution shell.
 1 SAD-Se
Space group C2221
Unit-cell parameters (A ˚ ) a = 96.54, b = 133.13, c = 92.54
Data collection
Wavelength (A ˚ ) 0.9791
Resolution range (A ˚ ) 29.9–1.70 (1.74–1.70)
No. of observations 323104
No. of unique reﬂections 65104
Completeness (%) 99.2 (96.6)
Mean I/ (I) 11.7 (2.0)
Rmerge on I† (%) 10.7 (71.6)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.9–1.70
No. of reﬂections (total) 65081‡
No. of reﬂections (test) 3297
Completeness (%) 99.0
Data set used in reﬁnement  1 SAD-Se
Cutoff criterion |F|>0
Rcryst§ 0.138
Rfree} 0.169
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond lengths (A ˚ ) 0.015
Bond angles ( ) 1.64
Average isotropic B value (A ˚ 2) 21.7††
ESU‡‡ based on Rfree value (A ˚ ) 0.08
Protein residues/atoms 574/4454
Water molecules/solvent/ions 566/29/4
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ The number of unique
reﬂections used in reﬁnement is typically slightly less than the total number that were
integrated and scaled. Reﬂections are excluded owing to systematic absences, negative
intensities and rounding errors in the resolution limits and unit-cell parameters. § Rcryst
=
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. } Rfree isthe same as Rcryst but for 5.1% of the
total reﬂections chosen at random and omitted from reﬁnement. †† This value
represents the total B that includes TLS and residual B components. ‡‡ Estimated
overall coordinate error (Collaborative Computational Project, Number 4, 1994;
Cruickshank, 1999).Blu-Ice (McPhillips et al., 2002) data-collection environment. The
SAD data were integrated and reduced using MOSFLM (Leslie,
1992) and scaled with the program SCALA (Collaborative Compu-
tational Project, Number 4, 1994). Selenium-substructure solution
and phasing were performed with SHELXD (Sheldrick, 2008) and
autoSHARP (Bricogne et al., 2003; the mean ﬁgure of merit was 0.32
with 25 selenium sites). Automatic model building was performed
with ARP/wARP (Cohen et al., 2004). Model completion and
reﬁnement were performed with Coot (Emsley & Cowtan, 2004) and
REFMAC v.5.4 (Winn et al., 2003). The reﬁnement included experi-
mental phase restraints (Pannu et al., 1998) in the form of
Hendrickson–Lattman coefﬁcients from SHARP and TLS reﬁnement
with one TLS group per chain. Data and reﬁnement statistics for
BB2672 are summarized in Table 1.
For SPO0826, multiple-wavelength anomalous diffraction (MAD)
data were collected on beamline BL9-2 at SSRL at wavelengths
corresponding to the high-energy remote ( 1), inﬂection ( 2) and
peak ( 3) of a selenium MAD experiment. The data sets were
collected at 100 K on a MAR Mosaic 325 mm CCD detector using
Blu-Ice (McPhillips et al., 2002). The MAD data were integrated and
reduced using XDS and scaled with the program XSCALE (Kabsch,
1993). Selenium-substructure solution and phasing were performed
with SHELXD (Sheldrick, 2008) and autoSHARP (Bricogne et al.,
2003; the mean ﬁgure of merit was 0.60 with four selenium sites) and
automatic model building was performed with iterative RESOLVE
(Terwilliger, 2003). Model completion and reﬁnement were per-
formed with Coot (Emsley & Cowtan, 2004) and REFMAC v.5.2
(Winn et al., 2003) using the high-energy remote ( 1) data set. The
reﬁnement included experimental phase restraints (Pannu et al.,
1998) in the form of Hendrickson–Lattman coefﬁcients from SHARP
and TLS reﬁnement with one TLS group. Data and reﬁnement
statistics for SPO0826 are summarized in Table 2.
2.3. Validation and deposition
The quality of the crystal structure was analyzed using the JCSG
Quality Control server (http://smb.slac.stanford.edu/jcsg/QC). This
server processes the coordinates and data through a variety of vali-
dation tools including AutoDepInputTool (Yang et al., 2004),
MolProbity (Davis et al., 2007), WHAT IF v.5.0 (Vriend, 1990),
RESOLVE (Terwilliger, 2003) and MOLEMAN2 (Kleywegt, 2000),
as well as several in-house scripts, and summarizes the results. Protein
quaternary-structure analysis used the PISA server (Krissinel &
Henrick, 2007). Fig. 1(b) was adapted from an analysis using PDBsum
(Laskowski et al., 2005) and all other ﬁgures were prepared with
PyMOL (DeLano Scientiﬁc). Atomic coordinates and experimental
structure factors for BB2672 at 1.7 A ˚ resolution and for SP0826
at 2.1 A ˚ resolution have been deposited in the PDB (http://
www.pdb.org) and are accessible under codes 3byq and 2qtp,
respectively.
3. Results and discussion
3.1. Overall structure
The crystal structure of BB2672 (Fig. 1) was determined to 1.7 A ˚
resolution using the SAD method (Table 1). The ﬁnal model included
three protomers (residues 2–192 of chain A, residues 1–192 of chain B
and residues 2–192 of chain C), two tetraethylene glycol (PEG)
molecules, 27 ethylene glycol molecules, four chloride ions and 566
water molecules in the asymmetric unit. No electron density was
observed for Gly0 (which remained from the N-terminal expression
and puriﬁcation tag after TEV cleavage) in all three chains or for
SeMet1 of chains A and C. Side-chain atoms of Lys73 in chain A,
SeMet1, Gln26, Lys73 and Asp74 in chain B, and Gln26 and Lys73 in
chain C had poorly deﬁned electron density and were omitted from
the model. The Matthews coefﬁcient (VM; Matthews, 1968) for
BB2672 was 2.3 A ˚ 3 Da
 1 and the estimated solvent content was
46.9%. The Ramachandran plot produced by MolProbity (Davis et
al., 2004) showed that 97.1% of the residues were in favored regions,
with no outliers.
The crystal structure of SPO0826 was determined to 2.1 A ˚ reso-
lution using the MAD method (Table 2). The ﬁnal model included
one protomer (147 of 194 residues) and 42 water molecules in the
asymmetric unit. No electron density was observed for residues from
the expression and puriﬁcation tag, SeMet1–Thr2, Gly103–Ala115,
Lys137–His145 or Gly172–Arg193. Side-chain atoms of Lys3, Ala18,
Arg20, Arg72, Glu74, Glu77, Glu87, Lys101, Leu116 and Lys122 had
poorly deﬁned electron density and were omitted from the model.
The Matthews coefﬁcient (VM; Matthews, 1968) for SPO0826 was
2.5 A ˚ 3 Da
 1 and the estimated solvent content was 51.6%. The
Ramachandran plot (Davis et al., 2004) showed that 95.8% of the
residues were in favored regions, with no outliers.
BB2672 forms a single domain composed of seven  -strands
( 1– 7; residues 6–16, 28–38, 78–85, 118–122, 129–135, 146–150 and
160–168), three  -helices (H1, H3 and H4; residues 50–71, 92–95 and
97–108) and three 310-helices (H2, H5 and H6; residues 73–75, 142–
144 and 182–184) (Fig. 1). The total  -sheet,  -helical and 310-helical
contents were 29.3, 19.9 and 4.7%, respectively. BB2672 contains a
structural communications
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Table 2
Summary of crystal parameters, data-collection and reﬁnement statistics for
SPO0826 (PDB code 2qtp).
Values in parentheses are for the highest resolution shell.
 1 MAD-Se  2 MAD-Se  3 MAD-Se
Space group P43212
Unit-cell parameters (A ˚ ) a = b = 94.73, c = 47.15
Data collection
Wavelength (A ˚ ) 0.9116 0.9792 0.9791
Resolution range (A ˚ ) 27.3–2.10
(2.15–2.10)
27.3–2.10
(2.15–2.10)
27.3–2.10
(2.15–2.10)
No. of observations 91717 91261 91289
No. of unique reﬂections 13007 13003 13021
Completeness (%) 99.7 (98.6) 99.6 (98.3) 99.7 (99.7)
Mean I/ (I) 20.6 (2.7) 17.0 (2.6) 17.5 (2.5)
Rmerge on I† (%) 4.8 (79.5) 6.2 (87.5) 6.2 (89.1)
Model and reﬁnement statistics
Resolution range (A ˚ ) 27.3–2.10
No. of reﬂections (total) 12970‡
No. of reﬂections (test) 631
Completeness (%) 99.5
Data set used in reﬁnement  1 MAD-Se
Cutoff criterion |F|>0
Rcryst§ 0.204
Rfree} 0.259
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond lengths (A ˚ ) 0.017
Bond angles ( ) 1.68
Average isotropic B value (A ˚ 2) 60.2††
ESU‡‡ based on Rfree value (A ˚ ) 0.17
Protein residues/atoms 147/1103
Water molecules 42
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ The number of unique
reﬂections used in reﬁnement is typically slightly less than the total number that were
integrated and scaled. Reﬂections are excluded owing to systematic absences, negative
intensities and rounding errors in the resolution limits and unit-cell parameters. § Rcryst
=
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factoramplitudes, respectively. } Rfree is the same as Rcrystbut for 4.9% of the
total reﬂections chosen at random and omitted from reﬁnement. †† This value
represents the total B that includes TLS and residual B components. ‡‡ Estimated
overall coordinate error (Collaborative Computational Project, Number 4, 1994;
Cruickshank, 1999).central ﬁve-stranded mixed  -sheet with 12734 topology that packs
against helices H1, H3 and H4. Two additional strands ( 5– 6) ﬂank
the sheet from the opposite side.
SPO0826 also forms a single domain composed of seven  -strands
( 1– 7; residues 4–17, 20–36, 78–85, 119–123, 130–134, 147–151 and
161–170), but with only two  -helices (H1 and H3; residues 48–69 and
91–97) and one 310-helix (H2; residues 73–75). The total  -sheet,
 -helical and 310-helical contents were 43.5, 19.7 and 2.0%, respec-
tively.
3.2. Similarity between BB2672 and SPO0826
BB2672 and SPO0826 are closely homologous, with a sequence
identity of 39%, and share the same overall fold and tertiary
structure. Superposition of the two structures extends over 142
equivalent C
  atoms, with an r.m.s.d. of 1.4 A ˚ (Fig. 2a). The dis-
ordered residues in the SPO0826 structure correspond to a large
C-terminal region of BB2672 that encompasses helix H4 (residues
97–109), most of the H4– 4 loop (residues 110–115), the  5– 6 loop
(residues 137–145), including the 310-helix H5, and the C-terminal
region (residues 172–193) after  7, including 310-helix H6. In BB2672,
consecutive glycines (residues 101–102) located after the ﬁrst turn of
helix H4 (Fig. 1b) result in a break in the main-chain hydrogen
bonding of the helix, indicating a degree of structural plasticity in this
region. Gly102 is highly conserved among BB2672 homologs,
suggesting that the conformational ﬂexibility in H4 might have
functional implications. The region C-terminal of  7, including
310-helix H6, has high B values but is stabilized through interactions
with the  5– 6 loop that appear to be critical for formation of the
hexamer.
structural communications
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Figure 1
Crystal structure of BB2672 from B. bronchiseptica.( a) Stereo ribbon diagram of the BB2672 protomer color-coded from the N-terminus (blue) to the C-terminus (red).
Helices (H1–H6) and  -strands ( 1– 7) are indicated. (b) Diagram showing the secondary-structure elements of BB2672 superimposed on its primary sequence in
accordance with PDBsum (http://www.ebi.ac.uk/pdbsum). For BB2672, the  -helices (H1, H3 and H4), 310-helices (H2, H5 and H6),  -strands ( 1– 7) and  -turns ( ) are
indicated.3.3. Similarity to other proteins
BB2672 and SPO0826 both show signiﬁcant
structural similarity to proteins with the
Bacillus chorismate mutase-like (BCM-like)
fold (http://scop.mrc-lmb.cam.ac.uk/scop/data/
scop.b.e.bie.j.b.b.html), a ‘circular permutation’
variant of the thioredoxin-like fold (Qi &
Grishin, 2005). A FATCAT (Ye & Godzik, 2004)
database search identiﬁed several proteins with
this fold that had signiﬁcant structural similarities
to BB2672. Among these, the top hit was the
C-terminal domain of RmpM, an outer mem-
brane protein from Neisseria meningitidis (PDB
code 1r1m; Grizot & Buchanan, 2004), with a C
 
r.m.s.d. of 3.1 A ˚ and 7% sequence identity over
96 residues (Fig. 2b). Superposition with the
monofunctional chorismate mutase from Bacillus
subtilis (PDB code 2cht; Chook et al., 1993)
resulted in similar r.m.s.d. values (2.5 A ˚ with 10%
sequence identity over 86 residues; Fig. 2c). In
addition to the core BCM-like fold, BB2672
contains an extra N-terminal strand ( 1) and a
 -hairpin (strands  5– 6) inserted between the
third and fourth strands of the BCM  -sheet
(Fig. 2c). In RmpM, BB2672 strands  5– 6 are
replaced by two helices that extend out in the
opposite direction from the  -strands (Fig. 2b),
while the region C-terminal of BB2672 strand  7
is absent from both structures (Figs. 2b and 2c).
Analysis of BB2672 using the PISA server
(Krissinel & Henrick, 2007) indicated that a
hexamer was the likely quaternary form.
Analytical size-exclusion chromatography in
combination with static light scattering indicated
that both BB2672 and SPO0826 were hexamers
in solution. The BB2672 hexamer corresponds to
a ‘trimer of dimers’ with approximate dimensions
of 50   70   80 A ˚ , with the helices positioned on
the outside and the  -strands forming the inner
core (Fig. 3a). This arrangement creates two main
types of interface. The interface between chains
B and C (and equivalents between A and A0 and
between C0 and B0;F i g .3 a) is extensive, burying a
surface area of 1960 A ˚ 2 per protomer with 32
hydrogen bonds and six salt bridges. This inter-
face involves strands  4– 6 and helix H5 from
both protomers, and the ﬁrst turn of helix H4,
loops  2–H1 and  3–H3 from one protomer that
contacts the region C-terminal of  7 in the other
protomer. Two strictly conserved pairs of salt
bridges (Glu90–Arg176 and Glu92–Arg172)
account for the majority of the electrostatic
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Figure 2
Stereo ribbon diagrams comparing BB2672 with other
related homologs. (a) Superposition of BB2672 (gray; PDB
code 3byq) and SPO0826, a DUF1185 homolog from
S. pomeroyi (blue; PDB code 2qtp). (b) Superposition of
BB2672 (gray) with the OmpA-like domain of RmpM from
N. meningitidis (blue; PDB code 1r1m) and (c) with the
monofunctional chorismate mutase from B. subtilis (blue;
PDB code 2cht).interactions along this interface. Both sets of salt bridges are almost
entirely shielded from solvent upon oligomerization. Residues in the
ﬁrst half-turn of helix H3, loop  2–H1, loop  3–H3 and the region
C-terminal of  7 are also highly conserved, suggesting that this
interface serves a conserved functional purpose. Analysis of the
BB2672 hexamer structure indicates that this ‘C-terminal’ or ‘dimer’
interface may provide dimers as the initial oligomerization building
blocks which then assemble to form the hexamer. However, this
interface was not observed in the SPO0826 structure, which crystal-
lized with a single molecule in the asymmetric unit.
The second interface, which is observed in both the BB2672 and
the SPO0826 structures, is formed between chains A and B (and
equivalently between C and C0 and between B0 and A0;F i g .3 a). This
‘N-terminal’ interface mainly involves interaction of the  1 strands of
adjacent chains in an antiparallel manner to form a continuous
 -sheet across interacting protomers. In BB2672 this,interface buries
a surface area of 950 A ˚ 2 per protomer with 18 hydrogen bonds and
four salt bridges. Pairs of intermolecular salt bridges (Lys8–Glu14
and Glu19–Arg7) anchor the adjacent ends of the corresponding  1
strands. With the exception of the strictly conserved Arg7–Glu19 salt
bridge, no other highly conserved intermolecular interactions are
observed in this interface. In BB2672, the N-terminal interface is
involved in the formation of the hexamer, while in SPO0826, it is only
involved in crystal contacts. This interface is not predicted by PISA
(Krissinel & Henrick, 2007) to form a stable dimer and thus seems to
only be stable when the molecules assemble as a hexamer. Both the
 1 strand and the region C-terminal of strand  7 are absent in classic
BCM folds, where the subunits are arranged in parallel to form
homotrimers (Chook et al., 1993; Fig. 3b). Thus, the two distinct types
of interface observed in the BB2672 hexamer could result from these
two novel additions to the classic BCM-like fold.
Analysis of the BB2672 hexamer structure using the CastP server
(Binkowski et al., 2003) revealed a large cavity ( 1000 A ˚ 3) located
along the C-terminal or dimer interface and including residues from
helix H4, the H4– 4 loop,  5, the  5–H5 loop, the 310-helix H5 and
the region C-terminal of  7. Proximal to this cavity, a highly con-
served cluster of four histidines, His93, His98, His144, His174, is
located within hydrogen-bonding distance of residues involved in the
formation of intermolecular salt bridges (Fig. 4). All four histidines
are located in potentially ﬂexible regions of the molecule: His144 and
His174 in loops and His87 and His98 at the beginning of helices H3
and H4, respectively. Helix H3 is a very short 310-helix, whereas His98
is located on a turn before a break in the main-chain hydrogen-
bonding pattern of helix H4. In SPO0826, most of these regions are
disordered, indicating ﬂexibility. This clustering of histidine residues
in regions of some conformational variability and the proximity of
salt bridges involved in oligomerization suggests that assembly of the
BB2672 hexamer could be modulated by pH or salt concentration.
The imidazole of the strictly conserved His144 is the only solvent-
exposed side chain of these His residues in the structure, suggesting
that it is the less solvent-accessible histidines that are likely to control
pH-dependent oligomerization. The observation that SPO0826
crystallizes as a monomer in high salt and acidic pH (2 M NaCl pH
6.5), while demonstrating the same hexameric oligomerization state
in solution as BB2672 under alkaline and low-salt conditions
(150 mM NaCl pH 8.0), lends further support to the hypothesis that
pH or salt concentration might be a key factor in oligomerization.
RmpM, the most similar structure to BB2672, is a putative
peptidoglycan-binding protein that interacts with integral outer
membrane proteins such as porins and with transporters implicated in
iron acquisition and bacterial pathogenesis (Grizot & Buchanan,
2004). The peptidoglycan-binding site is located along a highly
conserved hydrophilic groove that partially overlaps with a cavity
containing highly conserved residues along the C-terminal dimer-
ization interface of BB2672 (His93, Arg176 and Glu90; Grizot &
Buchanan, 2004). However, structural alignment shows no sequence
similarity between BB2672 and the proposed binding residues in
RmpM, and access tothe cavity in BB2672 is partially occluded by the
 2–H1 and  3–H3 loops.
In the monofunctional chorismate mutase from Bacillus subtilis
(PDB code 2cht), the active sites are located at each of the three
subunit interfaces and the reaction involves stabilization of the
charged transition state of chorismate via the formation of ionic
bonds with a number of acidic and basic side chains in BCM (Chook
et al., 1993). A number of studies have established that these
electrostatic effects provide the main drive in catalysis (Kast et al.,
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Figure 3
Oligomerization states of BB2672 and monofunctional BCM. (a) Ribbon diagram
of the BB2672 hexamer showing the arrangement of consecutive subunits (top
view). The three molecules present in the asymmetric unit are labeled A, B and C in
red. A0, B0 and C0 are the corresponding crystallographically related molecules that
together form the BB2672 hexamer. Protomers with their N-terminus pointing to
the front are shown in gray and those with their N-terminus pointing towards the
back are shown in blue. The C-terminal ‘dimer’ interface occurs between protomers
B–C, B0–C0 and A–A0. The N-terminal interface occurs between protomers A–
B, A0–B0 and C–C0.( b) Ribbon diagram of the BCM trimer (PDB code 2cht, top
view) showing the parallel arrangement of protomers resulting in three equivalent
interfaces.1996). Electrostatic catalysis can additionally be mediated by metal
ions and histidine proton shuttling (Christianson & Cox, 1999).
Although the C-terminal interface in BB2672 displays conservation
of an electrostatic surface analogous to monofunctional BCM, the
lack of sequence similarity between the two proteins, as well as their
different oligomerization states, makes it unlikely that they share a
common ligand. Assuming that the C-terminal interface plays a role
in environmental regulation of the BB2672 hexamer assembly, ligand
binding might occur along the less extensive and presumably less
stable N-terminal interface that is likely not formed prior to BB2672
hexamerization.
Several genes predicted (http://string.embl.de) to have functional
associations with BB2672 include putative exported proteins
(BB2673, BB0971 and BB4692), transcriptional regulators implicated
in pathogenesis and multiple antibiotic resistance (BB2675 and
BB1771) and various proteins (BB1772, BB1773 and BB1774)
involved in branched-chain amino-acid (BCAA; i.e. leucine, isoleu-
cine and valine) metabolism. A similar pattern is observed in the
genomic neighborhood of SPO0826, with several genes (SPO0822,
SPO0823, SPO0824 and SPO0825) involved in ATP-binding cassette
(ABC) type BCAA transport and this pattern is repeated again in
other BB2672 orthologs, lending further support to an association of
this family with amino-acid metabolism.
The BB2672 protein family (DUF1185; PF06684) contains more
than 200 sequence homologs, all of which are approximately 180
residues in length; they are mostly found in proteobacteria, but also
in ﬁrmicutes and uncultured bacteria from ocean, soil and human
microbiota. Members of the DUF1185 family are also present in
several human and animal pathogens from burkholderia and borde-
tella, as well as clostridia, where their genome location on virulence
islands suggests a possible role in pathogenesis (Nierman et al., 2004).
In some pathogenic bacteria, one of the modes of BCAA transpor-
tation is thought to be sensitive to stress induced by changes in
osmolarity, pH or temperature (Vijaranakul et al., 1998). In this
context, BB2672 and its homologs might present attractive drug
targets since, similar to chorismate mutases, DUF1185 homologs are
not found in mammals.
4. Conclusion
The structural similarities between BB2672 and monofunctional
BCM, as well the genomic neighborhood of BB2672 and homologs,
appear to suggest involvement of the DUF1185 (PF06684) family in
amino-acid metabolism. However, the presence of additional
secondary-structure elements in BB2672 and differences in oligo-
merization states (hexamer for BB2672, trimer for BCM) andthe lack
of detectable sequence similarity between BB2672 and BCM make it
unlikely that BB2672 and BCM share the same ligands. Finally,
comparison of the BB2672 and SPO0826 structures led us to propose
that oligomerization and potentially function in the DUF1185 family
could be subject to pH or salt regulation. Thus, BB2672 homologs
may also act as environmental sensors, enabling bacterial adaptation
and survival under a range of conditions.
The availability of more DUF1185 sequences and structures should
shed light on the evolutionary history of this intriguing protein family.
The information presented here, in combination with further bio-
chemical and biophysical studies, should yield valuable insights into
the functional role of BB2672. Models for BB2672 homologs can be
accessed athttp://www1.jcsg.org/cgi-bin/models/get_mor.pl?key=3byqA.
Additional information about BB2672 and SPO0826 is available
from TOPSAN (Krishna et al., 2010) at http://www.topsan.org/
explore?PDBid=3byq and http://www.topsan.org/explore?PDBid
=2qtp, respectively.
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